Autolus Therapeutics PLC (AUTL)
NASDAQ: AUTL · IEX Real-Time Price · USD
3.34
-0.25 (-6.96%)
Aug 19, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue
|
2.33 | 1.72 | 2.91 | 1.41 | 1.69 | 1.21 |
| Revenue Growth (YoY)
|
35.86% | -41.02% | 106.68% | -16.89% | 39.69% | - |
| Gross Profit
|
2.33 | 1.72 | 2.91 | 1.41 | 1.69 | 1.21 |
| Selling, General & Admin
|
31.87 | 34.97 | 39.45 | 22.79 | 9.1 | 5.15 |
| Research & Development
|
134.79 | 134.89 | 105.42 | 36.15 | 16.01 | 10.44 |
| Other Operating Expenses
|
0.68 | 0 | 4.1 | 0 | 0 | 0 |
| Operating Expenses
|
167.33 | 169.86 | 148.97 | 58.94 | 25.11 | 15.59 |
| Operating Income
|
-165 | -168.15 | -146.06 | -57.53 | -23.42 | -14.38 |
| Interest Expense / Income
|
1.11 | 0 | 0 | 0 | 0 | 0 |
| Other Expense / Income
|
-0.12 | -1.89 | -7.06 | -5.5 | -0.04 | -0.05 |
| Pretax Income
|
-165.99 | -166.26 | -139.01 | -52.03 | -23.38 | -14.33 |
| Income Tax
|
-23.89 | -24.16 | -15.16 | -7.28 | -3.65 | -1.78 |
| Net Income
|
-142.1 | -142.09 | -123.85 | -44.75 | -19.73 | -12.55 |
| Net Income Common
|
-142.1 | -142.09 | -123.85 | -44.75 | -19.73 | -12.55 |
| Shares Outstanding (Basic)
|
72 | 52 | 43 | 32 | 14 | 10 |
| Shares Outstanding (Diluted)
|
72 | 52 | 43 | 32 | 14 | 10 |
| Shares Change
|
39.81% | 19.72% | 36.47% | 128.95% | 38.76% | - |
| EPS (Basic)
|
-1.97 | -2.76 | -2.88 | -1.42 | -1.43 | -1.26 |
| EPS (Diluted)
|
-1.97 | -2.76 | -2.88 | -1.42 | -1.43 | -1.26 |
| Free Cash Flow Per Share
|
-1.76 | -2.57 | -2.78 | -1.29 | -1.40 | -1.18 |
| Gross Margin
|
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin
|
-7081.50% | -9804.40% | -5022.80% | -4089.10% | -1383.20% | -1186.10% |
| Profit Margin
|
-6098.50% | -8285.40% | -4258.90% | -3180.60% | -1165.20% | -1035.50% |
| Free Cash Flow Margin
|
-5438.50% | -7722.40% | -4120.50% | -2889.60% | -1136.20% | -965.70% |
| Effective Tax Rate
|
14.39% | 14.53% | 10.91% | 13.99% | 15.62% | 12.40% |
| EBITDA
|
-156.43 | -160.6 | -134.4 | -50.32 | -22.37 | -13.85 |
| EBITDA Margin
|
-6713.50% | -9364.40% | -4621.60% | -3576.50% | -1321.40% | -1142.70% |
| Depreciation & Amortization
|
8.46 | 5.66 | 4.61 | 1.71 | 1.01 | 0.48 |
| EBIT
|
-164.88 | -166.26 | -139.01 | -52.03 | -23.38 | -14.33 |
| EBIT Margin
|
-7076.50% | -9694.30% | -4780.20% | -3698.00% | -1381.00% | -1182.10% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).